LT-ZMP001

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLT-ZMP001
Drug Alias Nameanti-inflammatory tetrapeptide (Logical Therapeutics)TNF receptor-1 antagonist (Logical Therapeutics)LT-ZMP001
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1A inhibitors
TargetsTumor necrosis factor receptor superfamily member 1A
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLogical Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLogical Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A